| Serial Number | 90545048 |
| Word Mark | RNAGADE |
| Filing Date | Wednesday, February 24, 2021 |
| Status | 733 - FOURTH EXTENSION - GRANTED |
| Status Date | Monday, March 4, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 1, 2022 |
| Pseudo Mark | RENAGADE RENEGADE |
| Goods and Services | Biochemical catalysts; Biochemical preparations for scientific purposes; Biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; Diagnostic preparations for clinical or medical laboratory use; Diagnostic preparations for scientific or research use; Diagnostic preparations used in science; Nucleic acid for laboratory use; Protein in raw material form for scientific and medical research; Reagents for research purposes; Reagents for scientific and research use; Active chemical ingredients for use in the manufacture of pharmaceuticals for treating rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders and reproductive disorders; Antioxidants for use in the manufacture of pharmaceuticals; Biochemicals for in vitro and in vivo scientific use; Biochemicals, namely, polypeptides for in vitro research use; Biochemicals, namely, polynucleotides for in vitro and in vivo scientific and research purposes; Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory or research use; Biometallic compounds for use in the manufacture of pharmaceutical preparations; Catalysts for chemical and biochemical processes; Cells for scientific, laboratory or medical research; Chemical additives for use in the manufacture of pharmaceuticals; Chemicals for use in the biochemical and chemical industry; Chemicals for use in the purification of proteins for in vitro use; Diagnostic reagents for clinical or medical laboratory use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Diagnostic reagents for scientific or research use; Enzymes for use in protein hydrolysis; Immunohistochemistry detection kits consisting of mouse secondary reagents, DAB chromogens, DAB buffers, peroxidase blocking reagent, and hematoxylin, for anatomic pathology purposes in the medical diagnostics industry; Laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; Nucleic acid isolation and purification kit consisting primarily of reagents and magnetic beads for scientific research purposes; Plant extracts for use in the manufacture of pharmaceuticals; Protein arrays and nucleotide arrays for scientific and medical research; Reagents for scientific or medical research use |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, May 26, 2021 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Renagade Therapeutics LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Cambridge, MA 02142 |
| Party Name | Renagade Therapeutics LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Cambridge, MA 02142 |
| Event Date | Event Description |
| Tuesday, March 5, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, March 4, 2024 | SOU EXTENSION 4 GRANTED |
| Monday, March 4, 2024 | SOU EXTENSION 4 FILED |
| Monday, March 4, 2024 | SOU TEAS EXTENSION RECEIVED |
| Saturday, October 21, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, October 19, 2023 | SOU EXTENSION 3 GRANTED |
| Thursday, October 19, 2023 | SOU EXTENSION 3 FILED |
| Thursday, October 19, 2023 | SOU TEAS EXTENSION RECEIVED |
| Saturday, March 11, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, March 9, 2023 | SOU EXTENSION 2 GRANTED |
| Thursday, March 9, 2023 | SOU EXTENSION 2 FILED |
| Thursday, March 9, 2023 | SOU TEAS EXTENSION RECEIVED |
| Friday, October 21, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, October 19, 2022 | SOU EXTENSION 1 GRANTED |
| Wednesday, October 19, 2022 | SOU EXTENSION 1 FILED |
| Wednesday, October 19, 2022 | SOU TEAS EXTENSION RECEIVED |
| Thursday, October 13, 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Thursday, October 13, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, October 13, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, October 13, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, October 13, 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, April 26, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, March 1, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 1, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, February 9, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, January 26, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, January 26, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, January 26, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, January 26, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, January 26, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, December 27, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Sunday, December 26, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Sunday, December 26, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, September 15, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, September 15, 2021 | NON-FINAL ACTION E-MAILED |
| Wednesday, September 15, 2021 | NON-FINAL ACTION WRITTEN |
| Wednesday, September 15, 2021 | ASSIGNED TO EXAMINER |
| Wednesday, May 26, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, February 27, 2021 | NEW APPLICATION ENTERED |